Showing results (951-960 of 988) with videos related to

Sort By:
Pageof 99
Internal Medicine Journal|May 9, 2015
Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New ZealandP N Britton, K Eastwood, B Paterson, et al.
Clinical Obesity|October 13, 2017
Overweight, obesity and adiposity in survivors of childhood brain tumours: a systematic review and meta-analysisK-W Wang, A Fleming, D L Johnston, et al.
Frontiers in Immunology|July 12, 2021
Multiple Country and Breed Genomic Prediction of Tick Resistance in Beef CattleFernando Flores Cardoso, Oswald Matika, Appolinaire Djikeng, et al.
Journal of Oral Rehabilitation|May 6, 2024
Association between tooth loss-related speech and psychosocial impairment with cognitive function: A pilot study in Hong Kong's older populationKa Yi Lee, Charlotte Cheuk Kwan Chan, Ching Yip, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 15, 2016
Visible and Near-Infrared Photothermal Catalyzed Hydrogenation of Gaseous CO2 over Nanostructured Pd@Nb2O5Jia Jia, Paul G O'Brien, Le He, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000
Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literatureB J Currie, D A Fisher, D M Howard, et al.
The Medical Journal of Australia|July 1, 2024
First stroke incidence, causes, treatments, and outcomes for Aboriginal Peoples in South Australia and the Northern Territory: a pilot prospective studyAngela Dos Santos Gumbaynggirr Kwiamble, Edmund Cheong, Anna H Balabanski, et al.
The Medical Journal of Australia|March 22, 2012
Murray Valley encephalitis: a review of clinical features, diagnosis and treatmentJames Knox, Raquel U Cowan, Joseph S Doyle, et al.
Journal of Neurology|July 17, 2026
Neurofilament light chain (NfL) as a surrogate outcome measure for GM2 gangliosidosesKyriakos Martakis, Nicolas J Abreu, Joshua J Baker, et al.
Blood|February 8, 2017
Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapyTimothy M Cox, Guillermo Drelichman, Renata Cravo, et al.
Pageof 99